0001713836-17-000001.txt : 20170808
0001713836-17-000001.hdr.sgml : 20170808
20170808172457
ACCESSION NUMBER: 0001713836-17-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170808
DATE AS OF CHANGE: 20170808
EFFECTIVENESS DATE: 20170808
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neuraptive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001713836
IRS NUMBER: 821914769
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-292379
FILM NUMBER: 171015765
BUSINESS ADDRESS:
STREET 1: 2697 TRAILRIDGE DR WEST
CITY: LAFAYETTE
STATE: CO
ZIP: 80026
BUSINESS PHONE: 303-736-9657
MAIL ADDRESS:
STREET 1: PO BOX 3441
CITY: WINTER PARK
STATE: CO
ZIP: 80482
D
1
primary_doc.xml
X0708
D
LIVE
0001713836
Neuraptive Therapeutics, Inc.
79114 US Hwy 40
Winter Park
CO
COLORADO
80482
303-736-9657
DELAWARE
None
None
Corporation
true
2017
David
M.
Jackson
PO Box 3441
Winter Park
CO
COLORADO
80482
Executive Officer
Biotechnology
Decline to Disclose
- 06b
false
2017-07-24
false
true
false
10000
1000000
25000
975000
false
1
0
0
0
false
Neuraptive Therapeutics, Inc.
David M. Jackson
David M. Jackson
Chief Executive Officer
2017-08-08